1. Introduction
===============

Cerebral arteries operate in a dynamic state of partial constriction (myogenic tone), providing the capacity to constrict or relax in response to changing levels of intraluminal pressure, shear stress and nerve activity. Myogenic tone is an intrinsic property of the smooth muscle, helping maintain constant total cerebral blood flow and adapting blood flow locally to meet metabolic demand. Myogenic constriction is driven primarily by membrane depolarization leading to Ca^2+^ influx ([@bib8; @bib23]), possibly with a contribution via stretch-activated calcium sensitization ([@bib58]). Myogenic tone is often superimposed by vasomotion in the form of synchronised oscillations in smooth muscle cell membrane potential (Em), Ca^2+^ and tension. Although the physiological function of vasomotion in general is unclear, it may help to maintain a constant blood supply in many tissues, including the brain ([@bib17; @bib20]).

One key influence of basal NO release in the middle cerebral artery appears to be suppression of both myogenic tone ([@bib14; @bib53; @bib68]) and vasomotion ([@bib9; @bib19]). This influence appears largely due to activation of BK~Ca~ ([@bib5; @bib37; @bib67]). So block of NO generation and/or BK~Ca~ provides a means to mimic an aspect of endothelial dysfunction that is an early feature of cardiovascular disease, including disease conditions that predispose to vasospasm ([@bib28; @bib63]). These conditions will also mimic the loss of NO observed after subarachnoid haemorrhage, where scavenging of NO by haemoglobin ([@bib40]) causes profound vasospasm ([@bib61]). Significantly, enhanced vasomotion (or vasospasm) can lead to a reduction of cerebral capillary blood flow and thus compromise of neuronal function ([@bib3; @bib56]).

Several mechanisms, including the rho-kinase pathway, can contribute to the development and maintenance of constriction in smooth muscle, alongside calcium entry. However, in many vascular beds, including the cerebral vasculature changes in smooth muscle intracellular Ca^2+^ (\[Ca^2+^\]~i~) concentration is critical for myogenic tone and vasomotion ([@bib19; @bib20; @bib67]). \[Ca^2+^\]~i~ increase involves release from intracellular stores and entry from the extracellular space via voltage-gated Ca^2+^ channels and non-selective cation channels, such as transient receptor potential channels (TRPC). Ca^2+^ influx through voltage-gated Ca^2+^ channels (VGCC) leads to global increases in smooth muscle cell \[Ca^2+^\]~i~ and constriction, and high voltage activated (L-type) Ca^2+^ channels appear central in this sequence ([@bib43; @bib47; @bib51]). These channels are expressed widely in vascular smooth muscle and their open probability increases over a physiologically relevant range (circa −50 to −30 mV) ([@bib35; @bib59]). Low voltage activated or T-type Ca^2+^ channels are also expressed in vascular smooth muscle of resistance arteries ([@bib4; @bib7; @bib34; @bib50; @bib55]). But although they are normally active in the range *circa* −60 to −40 mV, the characteristic rapid inactivation of these channels argues against a significant role at physiologically relevant membrane potentials in the vasculature. Despite this, they have been implicated in the maintenance of vascular tone in a variety of arteries, including rat cremaster ([@bib62]), rat basilar ([@bib50]) and middle cerebral ([@bib36]) arteries, and direct measurements have shown high voltage activated but nifedipine-insensitive Ca^2+^ currents, pharmacologically indistinguishable from T-type currents, in both guinea-pig and rat terminal mesenteric arteries ([@bib17; @bib48; @bib49]).

We recently reported that middle cerebral arteries develop intense and sustained constriction, associated with a very rapid form of vasomotion, when NOS and/or BK~Ca~ channels were blocked, to mimic endothelial dysfunction. Furthermore, both constriction and vasomotion depended on calcium entry via VGCCs and the oscillations in E~m~ were temporally linked to changes in smooth muscle \[Ca^2+^\]~i~ ([@bib67]). The temporally linked oscillations in E~m~, \[Ca^2+^\]~i~ and tension were similar to the widely described phenomenon of vasomotion, but displayed a much higher frequency (∼ 1 Hz as opposed to ∼ 0.1--0.2 Hz, [@bib67]). The intense "vasospastic vasomotion" was reversed by inhibition L-type Ca^2+^ channels and clearly involved a complex action of NO that appeared to include stimulation of BK~Ca~ channels and a cGMP-independent closure of VGCCs ([@bib67]). However, although a central role for VGCC, NO and BK~Ca~ was apparent, the importance of other ionic currents that might contribute to the rapid depolarizing oscillations was unclear.

Thus, the aim of the present study was to characterize the ionic mechanisms responsible for rhythmic oscillations in E~m~ and tension in rat isolated middle cerebral arteries following inhibition of BK~Ca~ channels and NOS. We probed channels that may lead to both depolarization (calcium, sodium and chloride channels) and repolarization (potassium channels). Our data suggest a novel role for both smooth muscle T-type Ca^2+^ channels and several potassium conductances in the both "vasospastic vasomotion" and the underlying maintenance of vasoconstriction.

2. Materials and methods
========================

2.1. Animals and tissue isolation
---------------------------------

Male Wistar rats (200--250 g) were killed by cervical dislocation followed by decapitation, following institutional guidelines for animal welfare and schedule 1 of the Animals (scientific procedures) Act 1986. The brain was removed and immediately placed in ice-cold Krebs solution. Segments of the middle cerebral artery (∼ 2 mm long) were dissected and stored in ice-cold Krebs for use within 30 min, with similar size vessels used in all experimental groups.

2.2. Experimental protocols
---------------------------

Segments of middle cerebral artery (internal diameter ∼ 150 μm) were mounted in a Mulvany--Halpern myograph (model 400A, Danish Myotechnology) in Krebs solution containing (mM): NaCl, 118.0, NaCO~3~, 24; KCl, 3.6; MgSO~4~·7H~2~O, 1.2; glucose, 11.0; CaCl~2~, 2.5; gassed with 20% O~2~, 5% CO~2~ and balance N~2~ and maintained at 37 °C. After equilibration for 20 min, vessels were tensioned to 1--1.5 mN (approximates wall tension at 60 mmHg). Smooth muscle tension was recorded with an isometric force transducer and Powerlab software (ADI, Australia). Vessel viability was assessed by addition of exogenous K^+^ (15--55 mM, total K^+^ concentration); only vessels developing tension of ≥ 3 mN were used, following this Endothelial cell viability was assessed by the ability of the protease activated receptor 2 activating peptide; SLIGRL (20 μM) ([@bib1]) to relax U46619 induced tone (100 nM) by ≥ 75%, vessels with less relaxation were discarded. In some experiments, endothelial cells were removed by gently rubbing the luminal surface with a human hair; subsequent relaxation of \< 15% to SLIGRL (20 μM) was considered as successful removal and further abrasion often lead to damage of smooth muscle cells.

L-NAME (100 μM), indomethacin (10 μM) and iberiotoxin (100 nM) were added throughout the experiment (to block NO synthase (NOS), cyclooxygenase and BK~Ca~ channels, respectively), unless otherwise stated. In combination, these drugs gave a robust and sustained constriction (similar to vasospasm), and an associated rapid vasomotion. Similar responses were recorded in each case after inhibition of NOS alone, but vasomotion was more variable between preparations. Indomethacin had no effect on oscillations, but was included in the experimental cocktail to minimize any potential for confounding thromboxane signaling after NOS inhibition (Benyo et al., 1998; [@bib45]). Recordings were assessed in the presence of: the T-type (mibefradil 100 nM and NNC 55-0396 300 nM) and L-type (nifedipine 1 μM) Ca^2+^channel blockers, the K~Ca~ channel blockers, apamin (K~Ca~2.3 (SK~Ca~), 50 nM), TRAM-34 (K~Ca~3.1 (IK~Ca~), 1 μM), iberiotoxin (BK~Ca~, K~Ca~1.1, 100 nM) and charybdotoxin (K~Ca~3.1, B~Ca~, 100 nM), the K~IR~ channel inhibitors BaCl~2~ (30 μM) and CsCl~2~ (10 mM), the Na^+^/K^+^-ATPase inhibitor, ouabain (1 μM) and the voltage-gated K^+^ channel inhibitor, 4-aminopyridine (4-AP, 3 mM). Papaverine (150 μM) was added at the end of each experiment to assess overall tone. All blocking drugs were incubated for at least 20 min before data was recorded to ensure maximal effect. In most experiments smooth muscle membrane potential (E~m~) and tension were measured simultaneously as previously described, using glass microelectrodes (filled with 2 M KCl; tip resistance, 80--120 MΩ) to measure E~m~ ([@bib12]).

2.3. Data analysis and statistical procedures
---------------------------------------------

Results are expressed as the mean ± s.e. mean of *n* animals. Tension values are given in mN (always per 2 mm segment) and E~m~ as mV. During the vasospastic vasomotion E~m~ is expressed as the mean E~m~ over a random 10 s period of the rapid vasomotion where possible we have also reported the size of the depolarizing oscillations in mV. Vasodilatation is expressed as percentage reduction of the total vascular tone (myogenic tone plus vasoconstrictor response induced by either U46619 or the combination of L-NAME and iberiotoxin, as appropriate), quantified by relaxation with papaverine (150 μM). Graphs were drawn and comparisons made using either Student\'s t-test, or one-way ANOVA with Tukey\'s post-hoc test using Prism software (Graphpad, USA). P ≤ 0.05 was considered significant.

2.4. Drugs, chemicals, reagents and other materials
---------------------------------------------------

Exogenous K^+^ was added as an isotonic physiological salt solution in which all the NaCl was replaced with an equivalent amount of KCl. Concentrations of K^+^ used are expressed as final bath concentration. L-NAME (N^G^-nitro-[l]{.smallcaps}-arginine methyl ester), indomethacin, mibefradil, NNC 55-0396, nifedipine, barium chloride, cesium chloride, ouabain, 4-aminopyridine and papaverine were all obtained from Sigma (Poole, U.K.). U46619 (9,11-Dideoxy-11α,9α-epoxymethanoprostaglandin F2α) was from Calbiochem (UK). Apamin, charybdotoxin, iberiotoxin and tetrodotoxin from Latoxan (Valence, France). SLIGRL (serine--leucine--isoleucine--glycine--arginine--leucine--NH2) from Auspep (Parkville, Australia). TRAM-34 was a generous gift from Dr H. Wulff (University of California, Davis). All stock solutions were dissolved in distilled water except SLIGRL and charybdotoxin, dissolved in 0.9% NaCl, U46619 and TRAM-34, dissolved in dimethylsulfoxide (DMSO), nifedipine, dissolved in ethanol, and indomethacin which was dissolved in Na~2~CO~3~ (2%); vehicle controls were performed for drugs dissolved in DMSO ethanol and Na~2~CO~3~. All nomenclature conforms to the BJP guide to receptors and ion channels ([@bib1]).

3. Results
==========

3.1. Effect of inhibiting Nitric oxide synthase and BK~Ca~ on E~m~ and tension.
-------------------------------------------------------------------------------

Rat middle cerebral arteries developed spontaneous myogenic tone equivalent to 1.3 ± 0.1 mN (≈ 15% of maximum tension, with 55 mmol/L KCl, n = 40) with a resting membrane potential (E~m~) of −42.1 ± 0.9 mV (n = 40). Addition of the NOS inhibitor, L-NAME (100 μM), and the cyclooxygenase inhibitor, indomethacin (10 μM) tended to evoke smooth muscle cell depolarization (E~m~ −39.2 ± 1.0 mV, n = 38) and constriction (4.6 ± 0.2 mN, n = 40; *P* \< 0.05). In all vessels, the depolarization developed into ongoing oscillations (amplitude 7 ± 0.9 mV) followed by equivalent changes in tone (amplitude 0.12 ± 0.01 mN). We have previously reported similar observations in the rat middle cerebral artery following NOS inhibition alone ([@bib67]). With L-NAME present, stimulation of the endothelium with 20 μM SLIGRL evoked hyperpolarization of 20.9 ± 1.7 mV (n = 31) associated with 77.6 ± 3.6% relaxation (n = 37).

In the presence of L-NAME and indomethacin, the BK~Ca~ channel inhibitor, iberiotoxin (100 nM), evoked further depolarization (to E~m~ −35.7 ± 1.1 mV, n = 40; *P* \< 0.05) and constriction (to 5.7 ± 0.2 mN, n = 41; *P* \< 0.05), associated with a marked increase in the amplitude of oscillations in E~m~ temporally linked to tension ([Fig. 1](#fig1){ref-type="fig"}B). The oscillations in E~m~ and tension had a frequency of 0.84 ± 0.02 Hz and 0.80 ± 0.05 Hz and amplitude of 22.6 ± 1.3 mV and 0.19 ± 0.02 mN, respectively (n = 41). All subsequent experiments were performed in the presence of L-NAME, indomethacin and iberiotoxin unless stated. Removal of the endothelium abolished SLIGRL-mediated relaxation (20 μM), but failed to affect oscillations in E~m~ (frequency of 0.76 ± 0.10 Hz; amplitude of 19.4 ± 4.3 mV) and tension (frequency of 0.66 ± 0.10 Hz; amplitude of 0.16 ± 0.05 mN, n = 3).

3.2. \[Ca^2+^\]~o~ but not Na^+^ or Cl^−^ currents modify oscillations in membrane potential
--------------------------------------------------------------------------------------------

The voltage-dependent Na^+^ channel blocker, tetrodotoxin (1 μM) did not modify either the frequency or amplitude of oscillations in E~m~ (control: frequency of 0.84 ± 0.03 Hz, amplitude of 16.1 ± 1.4 mV; tetrodotoxin: frequency of 0.90 ± 0.02 Hz, amplitude of 15.4 ± 2.7 mV, n = 3) and tension (control: frequency of 0.73 ± 0.11 Hz, amplitude of 0.13 ± 0.01 mN; tetrodotoxin: frequency of 0.67 ± 0.14 Hz, amplitude of 0.12 ± 0.01 mN, n = 3).

To investigate if the oscillations were dependent upon Ca^2+^ influx, we decreased extracellular Ca^2+^ in steps from 2.5 to 0 mM. Simultaneous measurements of changes in E~m~ and tension showed that decreasing Ca^2+^ evoked depolarization (from −37.0 ± 2.1 to −26.8 ± 2.4 mV, n = 7; *P* \< 0.05) and relaxation (from 5.4 ± 0.6 to 0.3 ± 0.1 mN, n = 7; *P* \< 0.05). Under these conditions, the amplitude of oscillations in E~m~ and tension was diminished ([Fig. 1](#fig1){ref-type="fig"}C and D). The calcium-dependent Cl^−^ channel inhibitor, DIDS (150 μM), did not alter spontaneous oscillations in E~m~ or tension (data not shown) nor did it modify E~m~ (control: −44.4 ± 3.0 mV; DIDS: −49.2 ± 3.9 mV, n = 5) or tension (control: 4.7 ± 0.6 mN; DIDS: 3.6 ± 0.5 mN, n = 5).

3.3. Effect of Ca^2+^channel blockers on oscillations in E~m~ and tension
-------------------------------------------------------------------------

The T-type selective Ca^2+^ channel blocker, mibefradil (100 nM) abolished oscillations in E~m~ ([Fig. 2](#fig2){ref-type="fig"}A), significantly reduced oscillations in tension (control: frequency of 0.79 ± 0.07 Hz, amplitude of 0.16 ± 0.04 mN; mibefradil: frequency of 0.09 ± 0.05 Hz, amplitude of 0.04 ± 0.02 mN, n = 5; *P* \< 0.05) and evoked relaxation (control: 5.1 ± 0.7 mN; mibefradil: 3.5 ± 0.6 mN, n = 5) and depolarization (E~m~ control: −36.1 ± 1.3 mV; E~m~ mibefradil: −30.4 ± 2.5 mV, n = 5). The more selective T-type Ca^2+^ channel antagonist, NNC 55-0396 (300 nM) also significantly reduced oscillations in E~m~ ([Fig. 2](#fig2){ref-type="fig"}B) and in tension (control: frequency of 0.79 ± 0.09 Hz, amplitude of 0.17 ± 0.03 mN; NNC 55-0396: frequency of 0.20 ± 0.07 Hz, amplitude of 0.07 ± 0.02 mN, n = 6; *P* \< 0.05) and evoked relaxation (control: 5.5 ± 0.5 mN; NNC 55-0396: 3.0 ± 0.5 mN, n = 6; *P* \< 0.05). However, NNC 55-0396 did not significantly modify mean E~m~ (E~m~ control: −36.2 ± 3.2 mV; E~m~ NNC 55-0396: −31.9 ± 3.2 mV, n = 6). Further addition of the L-type voltage-gated Ca^2+^ channel inhibitor, nifedipine (1 μM), relaxed (control: 5.8 ± 0.7 mN; NNC 55-0396 3.5 ± 0.6 mN; NNC 55-0396 + nifedipine: 0.5 ± 0.1 mN, n = 4; *P* \< 0.05) and hyperpolarized (E~m~ control: −33.0 ± 3.7 mV; E~m~ NNC 55-0396: −30.0 ± 4.6; Em NNC 55-0396 + nifedipine: −36.7 ± 3.4 mV, n = 4; [Fig. 2](#fig2){ref-type="fig"}C). We also assessed the effect of NNC 55-0396 against middle cerebral artery basal myogenic tone in the absence of inhibitors. NNC 55-0396 (300 nM) did not significantly affect E~m~ (E~m~ control: −51.6 ± 2.47; E~m~ NNC 55-0396: −48.9 ± 2.0 mV, n = 5) or relax myogenic tone (control: 1.04 ± 0.18; NNC 55-0396: 0.69 ± 0.09 mN) under these conditions. The additional presence of nifedipine (1 μM) also failed to evoke hyperpolarization (E~m~ NNC 55-0396+ nifedipine: −51.5 ± 2.8 mV) but did cause significant relaxation (NNC 55-0396+ nifedipine: 0.44 ± 0.04 mN, n = 4, P \< 0.05). We have previously demonstrated similar relaxation of basal myogenic tone with nifedipine alone ([@bib67]).

3.4. Involvement of K~Ca~3.1(IK~Ca~) and K~Ca~2.3(SK~Ca~) channels
------------------------------------------------------------------

Addition of the K~Ca~3.1 channel blocker, TRAM-34 (1 μM) markedly decreased the amplitude of oscillations in E~m~ and tension ([Fig. 3](#fig3){ref-type="fig"}B) followed by small relaxation (control: 6.5 ± 0.4 mN; TRAM-34: 5.3 ± 0.2 mN, n = 5; *P* \< 0.05). TRAM-34 did not significantly reduce E~m~, (E~m~ control: −33.9 ± 2.6 mV; E~m~ TRAM-34: −28.7 ± 2.3 mV, n = 4). The effect of TRAM-34 on the amplitude of oscillations in E~m~ (control: 19.4 ± 4.3 mV; TRAM-34: 3.0 ± 1.6 mV, n = 3; *P* \< 0.05) and tension (control: 0.16 ± 0.05 mN; TRAM-34: 0.04 ± 0.02 mN, n = 3) was similar after endothelium removal. The oscillations in E~m~ and tension were not modified by the K~Ca~2.3 blocker apamin (50 nM), either alone ([Fig. 3](#fig3){ref-type="fig"}C) or in the additional presence of TRAM-34 ([Fig. 3](#fig3){ref-type="fig"}D). Likewise, charybdotoxin (100 nM) alone ([Fig. 4](#fig4){ref-type="fig"}B) or with apamin ([Fig. 4](#fig4){ref-type="fig"}C) did not affect either oscillations in E~m~ and tension ([Fig. 4](#fig4){ref-type="fig"}D and E), or mean tension and E~m~.

3.5. Involvement of K~IR~ channels, voltage-gated K^+^ channels and the Na^+^/K^+^-ATPase
-----------------------------------------------------------------------------------------

Inhibition of K~IR~ channels with BaCl~2~ (30 μM) did not affect the amplitude of oscillations in E~m~ (control: 31.1 ± 4.6 mV; BaCl~2~: 30.9 ± 6.1 mV, n = 5) or tension (control: 0.20 ± 0.03 mN; Ba^2+^: 0.19 ± 0.03 mV, n = 5). However, another inhibitor of K~IR~, CsCl (10 mM) increased the amplitude of oscillations in E~m~ (control: 30.8 ± 2.0 mV; CsCl: 40.4 ± 3.4 mV, n = 5; *P* \< 0.05), but not in tension (control: 0.20 ± 0.02 mN; CsCl: 0.19 ± 0.02 mV, n = 5), while 4-aminopyridine (4-AP; 3 mM to block K~v~) increased the amplitude of oscillations in both E~m~ (control: 17.75 ± 2.07; 4-AP: 30.62 ± 7.33 mV, n = 3) and tension (control: 0.17 ± 0.01; 4-AP: 0.25 ± 0.07 mN; n = 3, [Fig. 5](#fig5){ref-type="fig"}A). The Na^+^/K^+^-ATPase inhibitor, ouabain (1 μM) evoked relaxation (control: 5.8 ± 0.3 mN; ouabain: 4.6 ± 0.2 mN, n = 3; *P* \< 0.05) but without significantly reducing E~m~ (control: −42.2 ± 1.2 mV; ouabain: −38.4 ± 1.6 mV, n = 3). However, ouabain did reduce both the amplitude ([Fig. 5](#fig5){ref-type="fig"}B and C) and frequency (control: 0.97 ± 0.11 Hz; ouabain: 0.31 ± 0.16 Hz, n = 3; *P* \< 0.05) of oscillations in E~m~, without altering oscillations in tension ([Fig. 5](#fig5){ref-type="fig"}C and frequency control: 1.30 ± 0.22 Hz; plus ouabain: 0.92 ± 0.22 Hz, n = 3). The subsequent addition of 4-AP in the presence of ouabain caused depolarization (ouabain: −38.4 ± 1.6 mV; ouabain +4-AP: −34.6 ± 3.3 mV, n = 3; P \< 0.05), and increased oscillations in Em ([Fig. 5](#fig5){ref-type="fig"}C) and increased tension overall (ouabain: 4.6 ± 0.2 mN; ouabain + 4-AP: 5.5 ± 0.2 mN, n = 3; P \< 0.05).

4. Discussion
=============

This study provides the first demonstration, that rhythmic oscillations in membrane potential and tension as well as the associated spasm in rat isolated middle cerebral arteries following inhibition of BK~Ca~ channels and/or NOS reflect Ca^2+^ influx via T-type Ca^2+^ channels, in addition to L-type Ca^2+^ channels. These data extend our previous observation that NOS inhibition leads to L-type Ca^2+^ channel opening and arterial spasm, characterized by sustained constriction and superimposed by rapid vasomotion ([@bib67]). Vasomotion was of much higher frequency than previously recorded in other vascular beds, and as such we refer to it as 'vasospastic' vasomotion. We also provide evidence for modulation of both the Ca^2+^ dependent vasomotion and constriction through Na/K ATPase and a K^+^ conductance.

Consistent with previous work, our data suggest that calcium influx underlies rhythmic oscillations in the constricted rat middle cerebral artery, and that oscillations in membrane potential and tension are linked to oscillations in intracellular \[Ca^2+^\]~i~ as well as spasm in both middle cerebral and basilar arteries ([@bib19; @bib50; @bib67]). Reducing extracellular calcium diminished the amplitude of oscillations, led to relaxation and paradoxically depolarized the membrane. The relaxation presumably reflected the reduction in peak E~m~ associated with the reduced amplitude of oscillations in E~m~. Some small oscillations in tension did persist and may reflect vasomotion-independent intracellular calcium release, as reported in some arterial beds: for review see [@bib20]. As oscillations were insensitive to the calcium-dependent Cl^−^ channel inhibitor, DIDS and the voltage-dependent Na^+^ channel blocking agent, tetrodotoxin they certainly appeared to be mediated exclusively by calcium conductance. These data contrast with the basilar artery, where inhibition of Cl^−^ channels in this larger artery abolished calcium-dependent oscillations, leading to hyperpolarization and relaxation ([@bib19]) and parenchymal arterioles, where calcium-dependent oscillations were blocked with tetrodotoxin ([@bib11]). However, our data are consistent with human pial arteries, where tetrodotoxin was also without effect against oscillations in diameter ([@bib13]). In the present study, oscillations in muscle membrane potential were also resistant to direct damage of the endothelium, suggesting that this monolayer may not influence rapid vasomotion associated with arterial spasm.

In the rat middle cerebral artery, opening L-type Ca^2+^ channels is essential for vasoconstriction and vasomotion to develop, because inhibition of these channels abolishes vasomotion and fully reverses tone ([@bib67]). Surprisingly, in the present study under similar vasospastic conditions, oscillations in E~m~, and the associated oscillations in tension were abolished and followed by relaxation after calcium influx through T-type Ca^2+^ channels was blocked with mibefradil (at a concentration selective for block of T-type Ca^2+^ channels; 100 nM) or with a T-type Ca^2+^ channel selective, non-hydrolysable analogue of mibefradil, NNC 55-0396, ([@bib24]). Block of oscillations with the putative T-type Ca^2+^ channel blockers was not associated with a net hyperpolarization and complete relaxation, contrasting with the L-Type Ca^2+^ channel blocker nifedipine. So the effect of mibefradil or NNC 55-0396 is unlikely to reflect a non-specific effect against L-type channels. Furthermore, although mibefradil apparently reduced blood pressure and myogenic tone by an action on L-type calcium channels ([@bib46]), the lower concentration of mibefradil used in the present study is relatively specific against T-type Ca^2+^ channels. In fact, mibefradil seems only to inhibit the L-type Ca^2+^ channels after tissue metabolism ([@bib65]). The non-hydrolysable analogue of mibefradil NNC 55-0396 is selective for T-type Ca^2+^ channels, with no reported block of L-type Ca^2+^ channels even in concentrations as high as 100 μM ([@bib24]). Mibefradil has also been reported to block both Cl^−^ ([@bib2]) and Na^+^ ([@bib10; @bib15]) channels, but again with much higher concentrations (μM) than employed in the current study. Furthermore, the fact that blockers such as DIDs and TTX had no effect against vasospastic vasomotion makes an action of mibefradil against these channels extremely unlikely. Therefore, the differential effect of mibefradil and NNC-0396 compared to the selective blocker L-type Ca^2+^ channel blocker nifedipine indicates a critical role for T-type Ca^2+^ channels in vasospastic vasomotion. Further, these channels contribute significantly to the overall constriction in the middle cerebral artery.

Vasospastic vasomotion only developed once the smooth muscle cells depolarized to *circa* −40 mV, so it may be that T-type channels involved in vasomotion have gating properties similar to high voltage activated Ca^2+^ channels. This is surprising, as by definition T-type Ca^2+^ channels activate at low potentials and then quickly inactivate ([@bib35]). However, our data are consistent with studies reporting T-type Ca^2+^ channels that influence vascular tone and have properties similar to high voltage activated Ca^2+^ channels, ([@bib50]). Both T- and L-type Ca^2+^ channels are expressed in rat basilar ([@bib50]) and middle cerebral arteries ([@bib34]), and in each artery the CaV~3.2~ (or T-type) is the most abundant VGCC alpha subunit expressed. Human recombinant T-type Ca^2+^ channels ([@bib29]) and T-type Ca^2+^ channels co-expressed with auxiliary subunits ([@bib66]) do have gating properties similar to high voltage activated channels, so channels in the middle cerebral artery may be similar. Peripheral arteries also contain VGCCs with similar biophysical properties to high voltage activated channels (−50 to −20 mV), and are pharmacologically indistinguishable from T-type Ca^2+^ channels in both the guinea-pig and rat ([@bib48; @bib49]). In these small mesenteric arteries, T-type Ca^2+^ channels are the predominant voltage-gated subtype ([@bib16; @bib27]), and show increased window current due to non-inactivation at physiological E~m~ ([@bib26]).

As nifedipine abolished vasomotion, we propose that L-type channels are key for the initial depolarization and constriction ([@bib67]); whereas T-type are activated subsequently and as such is critical for the vasospastic vasomotion. Interestingly, input from T-type Ca^2+^ channels seems to be important for the initial constriction in the basilar artery, whereas L-type channels are critical for vasomotion ([@bib50]). But taken together, these results all suggest a functional coupling between L- and T-type Ca^2+^ channels, as previously suggested in renal ([@bib21]) and mesenteric arterioles ([@bib4]). As such, this might explain why neuroprotection in ischemic stroke is more effective in patients given blockers for more than just L-type VGCCs ([@bib32]).

As VGCC and hence vasospastic vasomotion are inhibited by a complex interaction between NO and smooth muscle cell BK~Ca~ channels in middle cerebral arteries, we attempted to characterize further the vasospastic vasomotion. Endothelial cell damage did not affect the vasomotion, so we inhibited a variety of K^+^ currents. Both inwardly rectifying and voltage-gated K^+^ channels participate in maintenance of resting membrane potential and vascular tone ([@bib31; @bib52; @bib60]). However, inhibition of K~IR~ channels with CsCl or barium did not affect vascular tone, although CsCl did slightly increase E~m~ oscillation amplitude. As Ba^2+^ was without effect, this small change most likely reflected a non-selective action of CsCl. Inhibition of K~v~ channels with 4-AP also had little effect, causing only a small increase in the amplitude of oscillations in E~m~ and tension. This is consistent with the reported role of these channels in rat mesenteric artery where inhibition of K~v~ increased rhythmic contractions ([@bib18]). So voltage-gated K^+^ channels did not appear to play any major role in vasospastic vasomotion.

Our data do suggest that Na^+^/K^+^-ATPase might contribute to vasomotion, as ouabain caused relaxation and reduced the amplitude and frequency of oscillations in E~m~, although surprisingly without affecting oscillations in tension. Ouabain can attenuate intercellular communication in smooth muscle ([@bib22; @bib39; @bib41]) and the synchronized changes in vascular \[Ca^2+^\]~i~ ([@bib33]) that lead to vasomotion ([@bib6; @bib42; @bib54]). So in part, ouabain may alter membrane potential oscillations by modifying cell--cell communication. Interestingly, ouabain effects were reversed by 4-AP, again indicating that K~V~ might contribute under some conditions to influence vasomotion.

The ability of the K~Ca~3.1 channel inhibitor TRAM-34 to reduce rather than enhance the amplitude of oscillations in E~m~ and tension was also unexpected. This effect was on the smooth muscle, as it was not altered by removal of the endothelium, and in contrast to TRAM-34, charybdotoxin, a mixed BK~Ca~ and K~Ca~3.1 inhibitor failed to modify the oscillations. One explanation is that TRAM-34 inhibits non-selective cation channels in the smooth muscle, similar to its action in isolated immune cells ([@bib57]). Non-selective cation channels are present in rat middle cerebral artery smooth muscle cells and appear to contribute to the calcium entry and vascular tone ([@bib38; @bib64]). So data with TRAM-34 suggest that non-selective cation channels may play an important role in the calcium entry events underpinning depolarization and vasomotion after NOS inhibition in the middle cerebral artery.

In summary, inhibition of either BK~Ca~ channels and/or NOS evokes vasospasm and fast, rhythmic oscillations in E~m~ and tension that are mediated by Ca^2+^ influx via both T-type and L-type Ca^2+^ channels. Our data suggest that the T-type channels are active at physiologically relevant membrane potentials and can therefore make an important contribution to the control of cerebrovascular blood flow during vasospasm associated with disease states where NO synthesis or action is impaired, such as cerebral ischemia or subarachnoid haemorrhage.
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![Original traces showing simultaneous recordings of membrane potential (upper panels) and tension (lower panels) in rat middle cerebral arteries under control resting conditions (A) or in the presence of L-NAME (100 μM), indomethacin (10 μM) and iberiotoxin (100 mN; B). Under control conditions, membrane potential and tension are relatively stable. In the presence of L-NAME, indomethacin and iberiotoxin, the smooth muscle cells depolarized and developed regular depolarizing oscillations, which were associated with constriction and oscillations in tension; the peaks in membrane potential immediately preceded peaks in tension. Decreasing extracellular calcium (from 2.5 to 0 mM Ca^2+^) caused depolarization and relaxation. Average data are shown in (C and D) showing the oscillation amplitude in membrane potential (C) and tension (D) in control vessels (2.5 mM Ca^2+^) and in the presence of 1, 0.5, 0.25 and 0 mM Ca^2+^. Data expressed as means ± S.E.M. \* *P* ≤ 0.05 indicates a significant difference from control by one-way ANOVA with Tukey\'s post-hoc test, n = 3--7.](gr1){#fig1}

![Original traces showing the effect of either (A) the T-type Ca^2+^ channel blocker, mibefradil (100 nM), (B) the more selective T-type Ca^2+^ channel antagonist, NNC 55-0396 (300 nM) or (C) the combined application of NNC 55-0396 (300 nM) and the L-type Ca^2+^ channel blocker, nifedipine (1 μM), on simultaneous recordings of membrane potential (upper panels) and tension (lower panels). Both mibefradil and NNC 55-0396 caused relaxation and abolished oscillations in membrane potential and tension; combined application of NNC 55-0396 and nifedipine caused greater hyperpolarization and relaxation than NNC-550396 alone, n = 4--6. Parallel lines (//) indicate a time break between same recordings from a single vessel the first time break shows the response at approximately 5 min post addition of drug the second time break corresponds to the maximum response which is approximately 15 min following addition.](gr2){#fig2}

![Original traces showing control conditions (A), the effect of the K~Ca~3.1 channel blocker, TRAM-34 (1 μM; B), the K~Ca~2.3 channel blocker, apamin (50 nM; C) or the combined application of TRAM-34 and apamin (D) on simultaneous recordings of membrane potential (upper panels) and tension (lower panels). Average data for oscillation amplitude in membrane potential (left panel) and tension (right panel) in control vessels and in the presence of TRAM-34, apamin and TRAM-34 + apamin are also shown (E). Data are expressed as means ± S.E.M. \* *P* ≤ 0.05 indicates a significant difference from control by one-way ANOVA with Tukey\'s post-hoc test, n = 3--9.](gr3){#fig3}

![Original traces showing control conditions (A) and the effect of either the BK~Ca~ and K~Ca~3.1 channel blocker, charybdotoxin (100 nM; B) or the combined application of charybdotoxin (100 nM) and the K~Ca~2.3 channel blocker, apamin (50 nM; C) on simultaneous recordings of membrane potential (upper panels) and tension (lower panels). Average data are shown for the oscillation amplitude in membrane potential (D) and tension (E) in control vessels and in the presence of charybdotoxin and charybdotoxin + apamin. Data expressed as means ± S.E.M. n = 3--4.](gr4){#fig4}

![Original traces showing (A) the effect of the voltage-gated K^+^channel inhibitor, 4-AP (3 mM) and (B) the effect of the Na^+^/K^+^-ATPase inhibitor, ouabain (1 μM) on simultaneous recordings of membrane potential (upper panels) and tension (lower panels). Average data are shown in (C) showing the oscillation amplitude in membrane potential (left panel) and tension (right panel) in control vessels and in the presence of ouabain and ouabain + 4-AP. Data expressed as means ± S.E.M. \*/^**+**^*P* ≤ 0.05 indicates a significant difference from either control or from ouabain alone, respectively, using one-way ANOVA with Tukey\'s post-hoc test, n = 3.](gr5){#fig5}
